BioCentury | Apr 14, 2017
Clinical News
Natesto regulatory update
...Hyundai Pharm. Co. Ltd. (KOSDAQ:A004310), Seoul, South Korea Product: Natesto (formerly CompleoTRT , TBS-1) Business: Endocrine/Metabolic
Alicia Parker
Natesto
Acerus Pharmaceuticals Corp.
Hyundai Pharm. Co. Ltd....